Evidence map›Paper›PMID 32350959›Full record

ArticleJournal of neuroendocrinology2020

GHR

Jonathan A Young, Brooke E Henry, Fabian Benencia, Stephen Bell, Edward O List, John J Kopchick, Darlene E Berryman

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroendocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Growth Hormone, Hypothalamic Inflammation, and Aging.Journal of obesity & metabolic syndrome · 2024
    Review
  8. Article
  9. Article
  10. Growth hormone receptor gene disruption.Vitamins and hormones · 2023
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jonathan A YoungEdison Biotechnology Institute, Ohio University, Athens, OH, USA.ORCID 0000-0003-1770-1391
Brooke E HenryEdison Biotechnology Institute, Ohio University, Athens, OH, USA.
Fabian BenenciaDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.
Stephen BellThe Diabetes Institute at Ohio University, Ohio University, Athens, OH, USA.
Edward O ListEdison Biotechnology Institute, Ohio University, Athens, OH, USA.
John J KopchickEdison Biotechnology Institute, Ohio University, Athens, OH, USA.
Darlene E BerrymanEdison Biotechnology Institute, Ohio University, Athens, OH, USA.
Biotechnology Institute · USOhio University · US

Funding

Modulating Growth Hormone Action as a Target for Improved Health and LongevityR01AG059779 · NIA · OHIO UNIVERSITY ATHENS · PI John Joseph Kopchick · 2018 to 2026
$4.7M
NIA NIH HHS R01 AG059779
6 · The paper itself

Abstract

Growth hormone (GH) excess in bovine (b)GH transgenic mice has been shown to alter white adipose tissue (WAT) immune cell populations. The present study aimed to evaluate the effects of GH resistance on WAT immune cell populations using GH receptor knockout (GHR

Indexed as

Abdominal FatAdipose Tissue, WhiteAgingAnimalsBody CompositionCarrier ProteinsCytokinesEpididymisGrowth HormoneImmunity, CellularInflammationMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicCarrier ProteinsCytokinesGrowth Hormonegrowth hormone, bovinesomatotropin-binding proteinadipose tissue macrophagesATMGHR−/− miceleukocytestromal vascular fractionSVFT cellsWATwhite adipose tissue

Identifiers

PMID32350959
PMCPMC7554100
OpenAlexW3015859934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.